| Wearable devices in clinical trials: hype and hypothesis ES Izmailova, JA Wagner, ED Perakslis Clinical Pharmacology & Therapeutics 104 (1), 42-52, 2018 | 209 | 2018 |
| Digital medicine: a primer on measurement A Coravos, JC Goldsack, DR Karlin, C Nebeker, E Perakslis, ... Digital biomarkers 3 (2), 31-71, 2019 | 133 | 2019 |
| Effective knowledge management in translational medicine S Szalma, V Koka, T Khasanova, ED Perakslis Journal of translational medicine 8, 1-9, 2010 | 129 | 2010 |
| Health care and cybersecurity: bibliometric analysis of the literature MS Jalali, S Razak, W Gordon, E Perakslis, S Madnick Journal of medical Internet research 21 (2), e12644, 2019 | 113 | 2019 |
| Cybersecurity in health care ED Perakslis N Engl J Med 371 (5), 395-397, 2014 | 105 | 2014 |
| Time for NIH to lead on data sharing I Sim, M Stebbins, BE Bierer, AJ Butte, J Drazen, V Dzau, AF Hernandez, ... Science 367 (6484), 1308-1309, 2020 | 48 | 2020 |
| Digital health—the need to assess benefits, risks, and value E Perakslis, GS Ginsburg Jama 325 (2), 127-128, 2021 | 43 | 2021 |
| HIPAA and the leak of “deidentified” EHR data KD Mandl, ED Perakslis N Engl J Med 384 (23), 2171-3, 2021 | 38 | 2021 |
| Using digital health to enable ethical health research in conflict and other humanitarian settings ED Perakslis Conflict and health 12 (1), 23, 2018 | 36 | 2018 |
| Continuous monitoring using a wearable device detects activity‐induced heart rate changes after administration of amphetamine ES Izmailova, IL McLean, G Hather, D Merberg, J Homsy, M Cantor, ... Clinical and translational science 12 (6), 677-686, 2019 | 33 | 2019 |
| Evaluation of wearable digital devices in a phase I clinical trial ES Izmailova, IL McLean, G Bhatia, G Hather, M Cantor, D Merberg, ... Clinical and Translational Science 12 (3), 247-256, 2019 | 32 | 2019 |
| A cybersecurity primer for translational research ED Perakslis, M Stanley Science translational medicine 8 (322), 322ps2-322ps2, 2016 | 28 | 2016 |
| Strategies for delivering value from digital technology transformation ED Perakslis Nature Reviews Drug Discovery 16 (2), 71-72, 2017 | 27 | 2017 |
| How informatics can potentiate precompetitive open‐source collaboration to jump‐start drug discovery and development ED Perakslis, J Van Dam, S Szalma Clinical pharmacology & Therapeutics 87 (5), 614-616, 2010 | 25 | 2010 |
| Is health-care data the new blood? E Perakslis, A Coravos The Lancet Digital Health 1 (1), e8-e9, 2019 | 23 | 2019 |
| Surface composition of carbon fibers subjected to oxidation in nitric acid followed by oxygen plasma ED Perakslis, SD Gardner, CU Pittman Journal of adhesion science and technology 11 (4), 531-551, 1997 | 23 | 1997 |
| Electronic medical records in humanitarian emergencies–the development of an Ebola clinical information and patient management system K Jobanputra, J Greig, G Shankar, E Perakslis, R Kremer, J Achar, ... F1000Research 5, 2016 | 19 | 2016 |
| Employ cybersecurity techniques against the threat of medical misinformation E Perakslis, RM Califf JAMA 322 (3), 207-208, 2019 | 15 | 2019 |
| Audit of data sharing by pharmaceutical companies for anticancer medicines approved by the US Food and Drug Administration ND Modi, AY Abuhelwa, RA McKinnon, AV Boddy, M Haseloff, MD Wiese, ... JAMA oncology 8 (9), 1310-1316, 2022 | 13 | 2022 |
| Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids E Perakslis, A Tuesca, A Lowman Journal of Biomaterials Science, Polymer Edition 18 (12), 1475-1490, 2007 | 13 | 2007 |
Andrea (Andy) CoravosHarvard-MIT Center for Regulatory Science, HumanFirstEmail verificata su gohumanfirst.com
